Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Warner-lambert Co.

Headquarters: United States of America
Website: N/A
Year Founded: N/A
Status: Merged

BioCentury | May 12, 2014
Strategy

Build up to break up

Why Pfizer needs AstraZeneca to make a break-up plan work
BioCentury | Nov 10, 2011
Targets & Mechanisms

Countering chemo-induced metastasis

BioCentury | Apr 18, 2011
Strategy

Supercharging Astex

SuperGen-Astex merger aims to create mid-tier cancer company
BioCentury | Jan 31, 2011
Strategy

Lysing what it sees

Amgen buying BioVex for OncoVEX immunotherapy based on Phase II melanoma data
BioCentury | Sep 2, 2010
Targets & Mechanisms

GSK's topoisomerase in the hole

BioCentury | Mar 8, 2010
Strategy

OSI Chronicles

BioCentury | Feb 1, 2010
Regulation

Begging questions about REMS

BioCentury | Jun 30, 2008
Strategy

Pfizer fleshing out its model

BioCentury | Mar 3, 2008
Politics, Policy & Law

Supreme preemption

BioCentury | Oct 1, 2007
Company News

Pfizer endocrine news

Items per page:
1 - 10 of 235